UWMRF Feature: Pantherics Receives SBIR Funding

Check out this exciting news regarding Pantherics, Inc., who conduct research at UWM and are developing an oral drug to treat multiple symptoms of asthma and other inflammatory conditions. They have recently received a Phase I Small Business Innovation Research grant from the National Institute of Health. To find out more, click here.